Arkolith/Insider Trading/BLPH/Form 4

Fernandes Peter

PRINCIPAL EXECUTIVE OFFICERBellerophon Therapeutics, Inc. (BLPH) · full profile →Form 4 · filed Dec 13, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 9, 2022Tax withholding(F)10K$0.93$9K23K
Dec 9, 2022Option exercise(M)33K——33K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 9, 2022Option exercise(M)33K—$033K

Transaction Codes

F
Shares withheld for taxes
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-22-012505) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML